In DC, where cannabis is legal but retail sales are prohibited, congressional leaders released an annual spending bill that blocks federal officials from punishing banks for working with marijuana businesses. The legislation also removes a longstanding rider that prevents the city of Washington, D.C. from spending its own money to legalize and regulate recreational cannabis sales. #cannabis #market #dc http://bit.ly/2Wgfxgn
As a nearly unanimous French Senate gave medical marijuana the green light on May 28, France will start experimenting with the use of medical marijuana for “about two years.” According to patient groups, somewhere between 300,000 and 1 million patients could be eligible to use cannabis to manage symptoms of cancer, certain types of epilepsy, multiple sclerosis, palliative care, and pain that does not respond to usual treatments. #france #cancer #epilepsy #multiplesclerosis #palliativecare #pain http://bit.ly/2WehBoY
A study in March found that daily use of high-potency cannabis is “strongly linked to the risk of developing psychosis.” But on June 1st, six scientists published a study in The Lancet, a British medical journal, that disputed this claim. The authors of the study note that correlation doesn’t equal causation. In other words, people with schizophrenia may be more likely to use cannabis, but there’s no evidence to suggest that it works the other way around. #psychosis #schizophrenia
The news: http://bit.ly/2WeuM9E
The articles & academic commentary: http://bit.ly/2Wf04wT
In a systematic review of studies investigating cannabis therapy for the treatment of chronic non-cancer pain (CNCP), evidence pointed to cannabinoids primarily effecting change with respect to neuropathy or MS-related pain. For CNCPs, it is unlikely that cannabinoids can be used as a single therapy, but rather in conjunction with other therapies. The quality of evidence in many of the studies reviewed was low, so further research needs to be completed in order to evaluate the efficacy of cannabinoids as a long-term treatment option for CNCPs.
Read more here:
This paper is stored here: http://bit.ly/2IgOLiG inside the CED Foundation Archive To explore related literature, click keywords below:
Amanda Reiman is among the most recognized women in cannabis. Reiman is VP of Community Relations for Flow Kana, the first sustainable, sun-grown cannabis group to represent small farmers within the Emerald Triangle. Awarded the 2017 Influencer of the Year by Industry Power Women, Reiman drives initiatives that ensure Flow Kana stands at the center of responsible cannabis. Learn more about Reiman’s work here: #womenincannabis #sustainability http://bit.ly/2Wn7gfB
John Boehner, the former speaker of the House, has spent his career opposing legalized marijuana. But now he sits on the board of Acreage Holdings, a marijuana investment firm whose profits hinge on Mr. Boehner’s ability to persuade Congress to legalize marijuana. The politician says that his views have “evolved,” and that he hopes cannabis will help veterans who suffer from PTSD as well as people who struggle with insomnia. #veterans #PTSD #insomnia
https://nyti.ms/2WlbpR0
Aside from medical benefits, the legalization of cannabis in India could bring about a multitude of benefits. The climate is good for growing the plant, so they could become a global player in terms of supply, all while giving the local economy a needed boost http://bit.ly/317NV0k
Bills protecting banks from federal punishment for doing business with companies in the cannabis industry are being submitted to Congress. While these bills have specific terms, they will open doors for permanent protection from punishment, which will let the industry flourish http://bit.ly/30Ya0OW
Medical cannabis users prefer vaping for fast, portable, discrete treatment
Previous research shows that medical cannabis users prefer vaporization, or vaping, as a means for drug administration. In a Brown University study, 25 consumers of medical cannabis were surveyed to further investigate this phenomenon. Participants largely preferred vaping over other forms of delivery. Patients cite increased cost efficiency, discrete use, more ease in transporting medication when traveling, and more immediate symptom relief as reasons for this preference. Based on these data, vaping may be a valuable drug delivery option for cannabis users seeking a discrete, portable, effective treatment vehicle. bit.ly/2W378N3
The Supreme Court of Brazil scheduled a voting session on decriminalization this coming Wednesday, but last week it was withdrawn from the court’s calendar. So, on Saturday, thousands of protestors gathered in Sao Paulo to participate in the March for the Decriminalization of Marijuana. Protestors begged lawmakers to decriminalize cannabis for both social justice and medical reasons. One protestor stated
“It is usually the poor and the blacks who get caught and sent to jail…You don’t see the rich kids from Jardins (an upper-class neighborhood) getting busted.”
In this sense, the protestor concluded, “criminalization becomes a weapon against the poor and blacks in this society.” Another protestor focused on the medical setbacks of criminalization, stating that, “I can imagine what it is like to have a son or daughter with a disease whose side effects can be reduced by the drug, but not able to get it because it is illegal.” Whether fighting for social justice or medical aid, the people of Brazil have spoken, and they encourage decriminalization. http://bit.ly/2W9ngNe
